Skip to main content
. 2020 Oct 27;53(2):399–408. doi: 10.4143/crt.2020.870

Fig. 1.

Fig. 1

Quantification and statistical analysis of N6-methyladenosine (m6A) from peripheral blood RNA in patients with breast cancer (BC), patients with benign breast diseases (BBD), normal controls (NCs), and noncancerous groups (NGs). m6A in peripheral blood RNA from 62 patients with BC, 41 patients with BBD and 41 NCs (A), or 82 patients from the NGs (B). Bars represent the mean±standard deviation of the results from replicate measurements.